评估饮食中黄酸盐摄入量与美国一般人口中便秘发病率之间的关系
Chenyu Jiang1, Jingyao Luo2, Yaojian Shao3
1Department of Geriatric, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, 318000, China.
BMC gastroenterology
|December 19, 2024
概括
饮食中较高的黄酸盐摄入量,特别是酸,与美国成年人中便秘的减少有关. 这项研究强调了黄类素在消化健康中的保护作用.
科学领域:
- 营养科学 营养科学
- 胃肠病学 胃肠病学
- 公共卫生 公共卫生
背景情况:
- 饮食调整是预防和治疗便秘的关键.
- 黄类药物会影响肠道微生物群,但它们与便秘的直接联系尚未得到充分研究.
研究的目的:
- 调查美国成年人口中饮食中黄类素摄入量与便秘之间的关系.
主要方法:
- 使用国家健康和营养检查调查 (NHANES) 数据 (2007-2010) 进行横截面分析.
- 通过饮食研究的食品和营养数据库 (FNDDS) 评估的食黄类摄入量.
- 便秘是由便一致性/频率定义的;使用加权后勤回归分析的关系.
主要成果:
- 在总类黄和子类 (异黄,酸,黄,黄,黄,黄) 和便秘之间观察到负相关性.
- 更高的安托西亚尼丁摄入量与便秘的几率降低相关,即使在调整后.
- 发现了反转的U形非线性关联,用于安托西亚尼丁,在0.92毫克摄入量以上看到了好处.
结论:
- 增加饮食中的黄类药物消费与美国成年人中便秘发病率较低有关.
- 安西氨酸与便秘发生率有着特别稳定的,反向的关系.
更多相关视频
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
133
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
133
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Assessment of the Gastrointestinal System I: Subjective Data
144
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
144
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
208
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
208
Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147


